Results 11 to 20 of about 13,261 (250)

Incomplete Presentations in Typical Chronic Inflammatory Demyelinating Polyneuropathy: A Single-Center, Retrospective Study. [PDF]

Muscle Nerve
ABSTRACT Introduction/Aims Incomplete forms of typical chronic inflammatory demyelinating polyneuropathy (CIDP) have recently been described, but their frequency and clinical characteristics are uncertain. This study aimed to describe a cohort of patients with incomplete typical CIDP.
Min YG, Ahmed I, Englezou C, Rajabally YA.   +3 more
europepmc   +2 more sources

Chronic Inflammatory Demyelinating Polyneuropathy [PDF]

Journal of the Neurological Sciences, 2019
Chronic inflammatory demyelinating polyneuropathy (CIDP) is immune-mediated neuropathy defined by clinical progression for more than 2 months, and electrodiagnostic evidence of peripheral nerve demyelination. However, there are several clinical phenotypes, classified into "typical CIDP," and "atypical CIDP" such as "multifocal acquired demyelinating ...
Sonoko Misawa, Satoshi Kuwabara
  +6 more sources

Hymenoptera sting as atypical causative factor for Guillain Barré Syndrome and chronic inflammatory demyelinating polyneuropathy – A case report and insights on pathophysiology [PDF]

Romanian Journal of Neurology, 2023
Introduction. Neurological manifestations secondary to Hymenoptera stings are rare. However, the literature describes cases of severe central and peripheral nervous system damage.
Cristina Gatcan, Thomas Gabriel Schreiner, Violeta Sapira, Cristina Grosu, Bogdan Emilian Ignat   +4 more
doaj   +1 more source

Patient-Reported Outcome Measures for Assessing Health-Related Quality of Life in Patients With Polyneuropathies, Focusing on Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy: A Systematic Review of Measurement Properties. [PDF]

J Peripher Nerv Syst
ABSTRACT Guillain‐Barre syndrome (GBS) and chronic inflammatory demyelinating polyneuropathy (CIDP) are immune‐mediated peripheral neuropathies. Despite treatment, patients may report residual deficits, pain, and fatigue with considerable impact on quality of life.
Pelouto F, Baars AE, Papri N, Haagsma JA, Jacobs BC, Terwee CB.   +5 more
europepmc   +2 more sources

Validation of the Medical Research Council sum score (MRCss) for use in Russian-speaking patients with chronic inflammatory demyelinating polyneuropathy

Нервно-мышечные болезни, 2023
Background. The use of rating scales and questionnaires is essential in an evaluation of disease course, treatment response, the disability level and quality of life in patients with chronic inflammatory demyelinating polyneuropathy. The Medical Research
N. A. Suponeva, A. S. Arestova, E. A. Melnik, A. A. Zimin, A. B. Zaytsev, A. Yakubu, E. S. Sherbakova, D. G. Yusupova, D. A. Grishina, E. V. Gnedovskaya, M. A. Piradov   +10 more
doaj   +1 more source

Neurosarcoidosis camouflaging as partial miller: Fisher syndrome

Indian Journal of Rheumatology, 2023
Neurological involvement in sarcoidosis has varied presentations. Peripheral neuropathy is one of them. Symmetrical axonal type sensory-motor polyneuropathy is the most common form; focal and multifocal neuropathy, polyradiculopathy, and vascular ...
B N Shiva Prasad, Subramanian Ramaswamy, Aumir Moin, Srinivas Nalloor   +3 more
doaj   +1 more source

Role of Imaging in Chronic Inflammatory Demyelinating Polyneuropathy: A Systematic Review [PDF]

Eur J Neurol
ABSTRACT Introduction Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is a treatable immune‐mediated neuropathy with a relapsing‐remitting course and symmetrical proximal and distal weakness. Diagnosis relies on nerve conduction studies (NCS) to detect demyelination but can be difficult in atypical cases.
Tozza S, Cassano E, Erra C, Muto M, Habetswallner F, Manganelli F.   +5 more
europepmc   +2 more sources

Ibrutinib-induced chronic demyelinating polyneuropathy in a 65-year-old man with chronic lymphoid leucosis: a clinical case [PDF]

Romanian Journal of Neurology, 2018
Relevance. Most of oncological patients undergo chemotherapy, which has a wide range of various toxic reactions including polyneuropathy. Ibrutinib is a relatively new medicine with a few side effects associated with peripheral polyneuropathy ...
N.A. Suponeva, D.A. Grishina, M.A. Piradov   +2 more
doaj   +1 more source

Chronic inflammatory demyelinating polyneuropathy with anti-contactin-associated protein 1 antibody and bile duct hamartomas in the liver: a case report

Journal of Medical Case Reports, 2022
Background Autoantibodies targeting node of Ranvier proteins are rarely reported in China. Case presentation We present the case of a 66-year-old Chinese man who concomitantly developed chronic inflammatory demyelinating polyneuropathy with anti ...
Shurong Hu, Yin Hu, Qiang Du
doaj   +1 more source

Chronic Inflammatory Demyelinating Polyneuropathy [PDF]

Journal of the Royal Army Medical Corps, 1994
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is a rare neurological disease. Definitive therapy is not yet established. We report our use of intravenous Immunoglobulin (iv IgG) in two cases of CIDP and review the therapeutic options available. Intravenous IgG is a ubiquitous practical treatment particularly in patients who do not respond to
I Salam, H Smith, L J Findley
openaire   +3 more sources